Caitlin Kontulis - 15 Feb 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Secretary & VP Finance & Admin
Signature
Caitlin Kontulis
Issuer symbol
PHIO
Transactions as of
15 Feb 2022
Transactions value $
$0
Form type
4
Filing time
16 Feb 2022, 19:10:37 UTC
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +68K +170.74% $0.00 108K 15 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
F2 Includes shares of common stock underlying unvested restricted stock units.